These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 32663910)

  • 1. The Covid-19 Vaccine-Development Multiverse.
    Heaton PM
    N Engl J Med; 2020 Nov; 383(20):1986-1988. PubMed ID: 32663910
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.
    Abu-Raya B; Gantt S; Sadarangani M
    CMAJ; 2020 Aug; 192(34):E982-E985. PubMed ID: 32646869
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 disrupts vaccine delivery.
    Nelson R
    Lancet Infect Dis; 2020 May; 20(5):546. PubMed ID: 32311326
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 5. The Race to Develop a COVID-19 Vaccine.
    Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riding the coronacoaster of uncertainty.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2020 Jun; 20(6):629. PubMed ID: 32422202
    [No Abstract]   [Full Text] [Related]  

  • 8. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Lodge A
    Lancet; 2020 Nov; 396(10261):1486. PubMed ID: 33160564
    [No Abstract]   [Full Text] [Related]  

  • 9. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Chauhan A; Agarwal A; Jaiswal N; Singh M
    Lancet; 2020 Nov; 396(10261):1485-1486. PubMed ID: 33160563
    [No Abstract]   [Full Text] [Related]  

  • 10. Next-generation vaccine platforms for COVID-19.
    van Riel D; de Wit E
    Nat Mater; 2020 Aug; 19(8):810-812. PubMed ID: 32704139
    [No Abstract]   [Full Text] [Related]  

  • 11. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 therapies and vaccine landscape.
    Nat Mater; 2020 Aug; 19(8):809. PubMed ID: 32704138
    [No Abstract]   [Full Text] [Related]  

  • 13. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
    Voysey M; Pollard AJ
    Lancet; 2020 Nov; 396(10261):1486-1487. PubMed ID: 33160565
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Jun; 16(696):1176-1177. PubMed ID: 32496711
    [No Abstract]   [Full Text] [Related]  

  • 15. Sarah Gilbert: carving a path towards a COVID-19 vaccine.
    Lane R
    Lancet; 2020 Apr; 395(10232):1247. PubMed ID: 32305089
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 and mRNA Vaccines-First Large Test for a New Approach.
    Abbasi J
    JAMA; 2020 Sep; 324(12):1125-1127. PubMed ID: 32880613
    [No Abstract]   [Full Text] [Related]  

  • 17. Ensuring global access to COVID-19 vaccines.
    Yamey G; Schäferhoff M; Hatchett R; Pate M; Zhao F; McDade KK
    Lancet; 2020 May; 395(10234):1405-1406. PubMed ID: 32243778
    [No Abstract]   [Full Text] [Related]  

  • 18. Covid-19 vaccine trial protocols released.
    Doshi P
    BMJ; 2020 Oct; 371():m4058. PubMed ID: 33087395
    [No Abstract]   [Full Text] [Related]  

  • 19. A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2.
    Hanley BP; Keen S; Church G
    Rejuvenation Res; 2020 Aug; 23(4):281-283. PubMed ID: 32539623
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 vaccines: early success and remaining challenges.
    Bar-Zeev N; Inglesby T
    Lancet; 2020 Sep; 396(10255):868-869. PubMed ID: 32896290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.